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 ABSTRACT 
 Hyperkalemia is a common complication in neonatal 
diarrheic dairy calves and is corrected by administra-
tion of glucose or sodium bicarbonate. Although the 
hypokalemic effect of glucose is well established in 
other species, controversial results are reported for 
sodium bicarbonate. Our objective was to study the 
effect and mechanism of action of glucose and sodium 
bicarbonate on the potassium homeostasis of healthy 
neonatal dairy calves. Nine healthy neonatal Holstein-
Friesian calves underwent 3 oral treatments with 2 
L of NaHCO3 (150 mmol/L), glucose (300 mmol/L), 
and glucose + NaHCO3 solution (300 mmol/L + 150 
mmol/L) in randomized order. Blood was obtained 
before treatment (T0) and at 30-min intervals there-
after. Changes between each time point and T0 were 
determined for all parameters. Urine was collected 
volumetrically to determine total renal potassium ex-
cretion over an 8-h posttreatment period. Plasma vol-
ume changes were extrapolated from changes in plasma 
protein concentration. Treatment and time effects were 
tested with repeated-measures ANOVA. Multivariate 
stepwise regression analysis using dummy variable 
coding was conducted to identify associations between 
changes in plasma potassium concentration ([K]) and 
changes in plasma glucose concentration ([glucose]), 
blood base excess, and plasma volume. Oral glucose 
and sodium bicarbonate treatments decreased [K] by 25 
and 19%, respectively, whereas the combination of both 
compounds caused an intermediate [K] decline (22%). 
For the glucose treatment, the decline in [K] was only 
associated with changes in plasma [glucose] (partial R2
= 0.19). In NaHCO3-treated calves, [K] decline was as-
sociated with change of extracellular volume (partial 
R2 = 0.31) and blood base excess (partial R2 = 0.19). 
When glucose and NaHCO3 were combined, [K] decline 
was associated with changes in plasma volume (partial 
R2 = 0.30), BE (R2 = 0.22), and [glucose] (partial R2 = 
0.03). Our results indicate that glucose lowers plasma 
[K] mainly through an insulin-dependent intracellular 
translocation of K, whereas NaHCO3 causes hypoka-
lemia through hemodilution followed by intracellular 
translocation of K caused by the strong ion effect. The 
combination of glucose and NaHCO3 at the dosage used 
in this study does not have an additive hypokalemic 
effect. When combined, hemodilution and strong ion 
effect have the strongest effect on plasma [K], whereas 
the insulin-dependent effect of glucose appears to be 
blunted. 
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 INTRODUCTION 
 Hyperkalemia is a common complication in calves 
with severe neonatal diarrhea and has the potential to 
cause life-threatening bradyarrhythmias. The presumed 
underlying mechanisms are decreased renal perfusion in 
dehydrated calves and decreased intracellular translo-
cation of potassium (K) in states of acidemia. Although 
treatment with glucose or insulin is well established for 
the treatment of hyperkalemia, the efficacy of sodium 
bicarbonate is controversial in several species (Kim and 
Han, 2002; Weisberg, 2008; Youn and McDonough, 
2009). In general, hyperkalemia in diarrheic calves is 
not addressed as an individual problem because cor-
rection of the K disequilibrium presumably occurs in 
response to the administration of oral and parenteral 
glucose, electrolytes, and sodium bicarbonate together 
with large amounts of fluids, which is common prac-
tice in these animals. To our knowledge, the effect 
and underlying mechanism of sodium bicarbonate and 
glucose on K homeostasis in calves has not yet been 
investigated. Therefore, the objectives of the present 
experiment were to study the effect of both compounds 
as well as the combination thereof on plasma K concen-
tration when administered orally to healthy, nonanuric, 
nonacidotic neonatal calves and to explore the underly-
ing mechanisms. 
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MATERIALS AND METHODS
All methods were approved by the Animal Care and 
Use Committee, Berlin, Germany (permit # 0384/10).
Animals, Housing, and Feeding
Nine healthy male Holstein-Friesian calves were ob-
tained from a commercial dairy farm between d 7 and 
14 of life. Calves were kept unrestrained in groups of 2 
in straw-bedded stalls in a climate-controlled environ-
ment. All animals were allowed a 6- to 8-d acclimation 
period during which their health status was monitored. 
A commercial casein-based milk replacer (Sprayfo 
Sprint, Sloten, Diepholz, Germany) with 22.5% CP, 
16% crude fat, 0.1% crude fiber, and 7.0% crude ash 
was fed twice daily (150 g of milk replacer/L of water, 
60 mL of solution/kg of BW, pH = 6.5, temperature 
= 38°C) at standardized times from a nipple bucket. 
Calves had access to fresh water ad libitum except for 
during an 8-h period following each experimental treat-
ment. All calves underwent a complete physical exam 
at least 12 h before the first treatment and had jugular 
catheters and urine collection bags fitted, as follows. A 
16-gauge, 83-mm catheter (Angiocath, Becton Dickin-
son, Heidelberg, Germany) was aseptically fitted in a 
jugular vein, and a urine collection bag with a connec-
tion port to attach tubing for urine collection was glued 
onto the hair around the preputium of the calves. Cath-
eters and urine collection bags remained in place for 5 d 
until the end of the study. Venous catheterization was 
performed after sedation with xylazine (0.2 mg/kg of 
BW i.m.), aseptic preparation of the skin, and injection 
of 1 mL of 4% procaine into and under the skin over the 
jugular vein to be catheterized. A small stab incision 
through the skin was made with a scalpel to facilitate 
the catheter placement. The catheter was placed into 
the vein, connected to an extension set (Discofix C-3, 
10 cm, Braun Melsungen AG, Melsungen, Germany), 
and secured in place with suture material. Catheters 
were flushed every 8 to 12 h with heparinized 0.9% 
NaCl solution (40 U of heparin/mL).
Experimental Protocol
Studies were conducted between d 15 and 24 of age 
and at least 12 h after the last feeding. Calves on trial 
were restrained with a fence placed in the stall in such 
manner that they could sit and stand easily but could 
not turn in a complete circle.
Treatment order was assigned randomly for each in-
dividual animal with a washout period of 48 h between 
treatments. On each trial day, calves were tube-fed 
between 0800 and 0815 h with one of following test 
solutions at approximately 38°C: 25.2 g of NaHCO3 in 2 
L of tap water (NaBic, 150 mmol/L); 118 g of glucose 
monohydrate in 2 L of tap water (Gluc, 300 mmol/L), 
or 25.2 g of NaHCO3 plus 118 g of glucose in 2 L of tap 
water (Combi). The solutions of groups NaBic and 
Gluc were formulated to be isotonic (300 mOsm/L). 
The test solution of group Combi was of double to-
nicity (600 mOsmol/L) but formulated to match the 
Na:glucose ratio of 1:2 on a molar basis recommended 
for oral electrolyte solutions for calves (Smith, 2009). 
Tube feeding was chosen over voluntary intake to stan-
dardize the ingestion time of the test solution, because 
different palatabilities of salt and glucose solution were 
likely to affect ingestion time.
Venous blood samples were obtained from the jugu-
lar catheter at 0 min (immediately before tube feed-
ing) as well as 30, 60, 90, 120, 150, 180, 210, 240, 300, 
360, 420, and 480 min after tube feeding. Blood for 
blood gas analysis was collected anaerobically into 
heparinized 1-mL plastic syringes that were immedi-
ately capped and analyzed within 10 min of collection. 
Blood for biochemical analysis was collected into 10-
mL tubes containing lithium heparin as anticoagulant 
and centrifuged within 10 min at 1,500 × g for 15 min 
at room temperature. Plasma was harvested and stored 
at −24°C until analyzed. Immediately after administra-
tion of the test solution, tubing connected to a 3-L col-
lection vial was attached to the connecting port of the 
urine collection bag to allow volumetric urine collection 
for a period of 8 h after the start of treatment. At the 
end of the 8-h period, the volume of urine collected 
was determined. A urine sample was obtained after 
thorough mixing and immediately frozen and stored at 
−24°C until analyzed.
Plasma samples were assayed for the concentra-
tions of sodium ([Na], flame atomic absorption spec-
trometry), potassium ([K], flame atomic absorption 
spectrometry), chloride ([Cl], ion selective electrode), 
glucose ([gluc], hexokinase method), and total protein 
([TP], biuret method). An automated chemistry ana-
lyzer (Cobas Mira Plus, Roche, Basel, Switzerland) was 
used for the plasma biochemical analysis, and flame 
atomic absorption spectrometry was conducted on a 
Solaar M6 spectrometer (Thermo Fisher Scientific, 
Schwerte, Germany). Blood gas analysis was performed 
on an automated blood gas analyzer (Radiometer 
AVL5, Brønshøj, Denmark). Measured values for blood 
pH, partial pressure of CO2, and partial pressure of 
O2 were corrected for rectal temperature and used to 
calculate the actual HCO3 concentration ([HCO3]) and 
the actual base excess (BE) using standard equations 
(Burnett et al., 1995). Urine was analyzed for urine [K] 
as described for plasma.
To crudely estimate volume changes of extracellu-
lar space that might have occurred after treatment, 
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changes in plasma volume at each time point i relative 
to time zero (T0) were extrapolated from the changes 
in [TP] as follows: VolDiffi (%) = ([TP0] − [TPi]) × 
100/[TPi] (Nouri and Constable, 2006).
The strong ion difference (SID3) was calculated from 
the plasma concentrations of Na, K, and Cl as follows: 
SID3 (mEq/L) = ([Na] + [K]) – [Cl]. To determine the 
kinetics of glucose absorption the increment of [gluc] 
relative to T0 was determined for each time point i 
using the equation GlucDIFFi = [gluci] – [gluc0]. In a 
similar manner, the changes (Diff) in concentration for 
each time point relative to T0 were determined for K 
(KDiffi), Na (NaDiffi), BE (BEDiffi), and SID3 (SID-
3Diffi). The change of the plasma [K] was corrected for 
plasma volume changes using the equation
VolCorrKDiffi (mmol/L) = KDiffi + VolDiffi.
The maximum decrement of [K] relative to T0 (Cmin-
Kdiff; baseline [K] − lowest [K] measured in the first 120 
min) as well as the time at which the lowest [K] was 
measured (TminKdiff) were obtained from a plot of the 
plasma concentration–time data.
The area under the plasma [gluc], [HCO3], BE, and 
VolDiff increment time curve for the first 4 h after 
treatment (AUCGlucDiff-240, AUCHCO3Diff-240, AUCBE-
Diff-240) as well as the area under the plasma [K] decre-
ment–time curve for the same time interval (AUCK-
diff-240) were calculated using the trapezoidal rule.
Statistical Analysis
Data are expressed as mean ± standard deviation 
(SD) or as median and interquartile range. A P-
value < 0.05 was considered significant. Values were 
log-transformed when necessary to achieve a normal 
distribution. Repeated-measures ANOVA was used 
to detect differences in measured parameters between 
treatment groups and over time using PROC MIXED 
(SAS 9.2, SAS Institute Inc., Cary, NC). Bonferroni-
adjusted P-values were used to assess differences within 
and between treatment groups whenever the F-test was 
significant.
The association between several determined param-
eters and KDiffi was tested using forward and backward 
multivariate stepwise linear regression analysis (P < 
0.05 for entry and exit) only including values obtained 
within the first 120 min of treatment. This time in-
terval was chosen because the decline in plasma [K] 
occurred and reached its nadir in all groups within this 
period. The analysis used a dummy variable coding for 
each calf, which accounted for between-calf variability, 
thereby increasing the precision with which slope and 
intercept coefficients for the regression line can be es-
timated (Glantz and Slinker 1990). This analytical ap-
proach enforces a uniform slope but different intercept 
value for each calf; this approach is appropriate when-
ever the slopes are similar, as in this study. Dummy 
variables (C1 to Cn) were defined as follows: C1 = 1 
if calf i (i < n), −1 if calf = n, and 0 otherwise. The 
parameters included in the multivariate stepwise linear 
regression analysis were VolDiff, as a proxy for changes 
in plasma and thus extracellular volume; GlucDiff, as a 
proxy for the increment of the plasma insulin concen-
tration following intestinal glucose absorption; BEDiff 
and SID3Diff as a proxy for change of the strong ion 
difference, according to Stewart’s strong ion model; 
and HCO3Diff as a proxy for the change in acid-base 
homeostasis, according to the Henderson-Hasselbalch 
model. Furthermore, NaDiff was included to identify 
a possible Na-dependent effect on plasma [K]. Pearson 
correlation analysis stratified by treatment group was 
conducted to identify possible associations of the total 
renal K excretion with the AUCKDiff-240 and Cmin-KDiff in 
plasma.
The SAS statistical software package was used for 
analysis (SAS 9.2; SAS Institute Inc.).
RESULTS
The plasma [K]–time curve declined with a similar 
slope and duration in all 3 treatment groups (Figure 1, 
upper panel). Although neither a treatment effect nor 
a treatment × time interaction was identified, the time 
effect on plasma [K] was significant (P < 0.0001), with 
a decline within 30 min of oral treatment in all groups. 
The nadir of the plasma [K] decrement (Tmin-KDiff) was 
reached after 87 ± 32 min in group NaBic, 110 ± 56 
min in group Gluc, and 124 ± 54 min in group Combi, 
with maximum decrements of plasma [K] (Cmin-KDiff) of 
−1.2 ± 0.2, −0.8 ± 0.4, and −1.0 ± 0.4 mmol/L in 
groups Gluc, NaBic, and Combi, respectively. These 
declines were equivalent to 25, 19, and 22% of the base-
line plasma [K] concentrations in groups Gluc, NaBic, 
and Combi, respectively. Treatment effects were not 
significant for either Tmin-KDiff or Cmin-KDiff. Plasma [K] 
remained below baseline values for at least 240 min 
in all groups (Figure 1a). The analysis of the plasma 
KDiff–time data revealed a significant time effect but 
also a treatment effect (P = 0.0227, Figure 1b), with 
a significantly more pronounced decrement in plasma 
[K] in Gluc compared with NaBic (P = 0.0009). The 
area under the [K] decrement time curve (AUCKDiff-240) 
was −182 ± 49 mmol/L·min in Gluc, −119 ± 70 
mmol/L·min in NaBic, and −162 ± 76 mmol/L·min 
in Combi. The treatment effect on AUCKDiff-240 was not 
significant. The analysis of the volume-corrected decre-
ment in plasma [K] (Figure 1c) yielded significant time 
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and treatment effects (P = 0.0185), with a significantly 
smaller decline of the volume-corrected plasma [K] in 
NaBic compared with Gluc (P = 0.0077) and Combi 
(P = 0.0347).
Renal K excretion did not differ significantly between 
groups during the 8 h following treatment (Figure 2). 
Pearson correlation analysis stratified by group re-
vealed significant associations of the total renal K ex-
cretion with Cmin-Kdiff (R = 0.861; P = 0.0029) and with 
AUCKDiff-240 (R = 0.764; P = 0.0164) in Gluc only, 
indicating that, in this group, the more pronounced 
the decline in plasma [K], the greater the decrease in 
total amount of K excreted in urine. Urine volumes 
produced over the 8 h immediately following oral treat-
ment were (median and interquartile range) 1,500 mL 
(1,150–1,700 mL), 1,170 mL (1,150–1,950 mL), and 
980 mL (750–2,000 mL) in Gluc, NaBic, and Combi, 
respectively.
Slope and amplitude of the plasma [glucose]–time 
curve were similar in Gluc and Combi (Figure 3). 
Group differences for Cmax-GlucDiff, Tmax-GlucDiff, and 
AUCGlucDiff\240 were identified between NaBic (not hav-
ing received any glucose) and the other groups. No dif-
ferences between Gluc and Combi were found.
Plasma volume changes extrapolated from the change 
in plasma [TP] are presented in Figure 4. Analysis of 
variance revealed a significant time effect (P = 0.0321) 
but not a treatment or treatment × time interaction. 
Plasma volume was significantly increased from 60 to 
150 min posttreatment. No treatment effect was deter-
mined on AUCVolDiff-240.
Changes in venous blood pH and BE over time are 
presented in Figure 5. Although venous blood pH was, 
and remained, within normal limits throughout the 
study in all groups, numerical increases after oral treat-
ment were observed in NaBic and Combi. Venous blood 
pH changes over time were significant in NaBic only. 
The blood BE increased significantly above baseline 
Figure 1. Mean plasma [K] ± SD (upper panel), mean change in 
plasma [K] relative to time zero (T0) ± SD (middle panel), and mean 
change in plasma [K] relative to T0 ± SD corrected for changes in plas-
ma volume relative to T0 (lower panel) in groups Gluc (300 mmol/L 
of glucose; ), NaBic (150 mmol/L NaHCO3; ?), and Combi (150 
mmol/L NaHCO3 + 300 mmol/L glucose; □). Samples were obtained 
at the same time points in all groups but time points were spread apart 
slightly to improve clarity.
Figure 2. Box and whisker plots representing total renal K excre-
tion during 8 h following treatment stratified by group. Box and whis-
ker plots represent median (horizontal line), lower and upper quartile 
(bottom and top of box, respectively), and second and ninth percen-
tiles (lower and upper end of whiskers, respectively). Group differences 
were not significant.
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values within 60 min of treatment in groups NaBic and 
Combi and remained above baseline values until the 
end of the study period. No time effect was observed 
in Gluc, this group not having received any sodium 
bicarbonate (Figure 5). Accordingly, the area under the 
BEDiff–time curve was significantly smaller for Gluc 
compared with the other 2 groups, whereas the differ-
ence between NaBic and Combi was not significant.
Forward multiple stepwise regression analysis con-
ducted by group with KDiff as dependent variable and 
VolDiff, BEDiff, HCO3Diff, SID3Diff, GlucDiff, and 
NaDiff as independent variables yielded a final model 
in which GlucDiff remained as the sole significant in-
dependent variable (partial R2 = 0.193, P = 0.0058) 
in Gluc. In NaBic, VolDiff (partial R2 = 0.3087, P < 
0.0001) and BEDiff (partial R2 = 0.1864, P < 0.0001) 
remained in the final model, and in Combi, VolDiff 
(partial R2 = 0.3017, P < 0.0001), BEDiff (partial R2 = 
0.2197, P < 0.0001), and GlucDiff (partial R2 = 0.0319, 
P = 0.0287) remained in the final model.
DISCUSSION
The results presented here revealed a marked plasma 
potassium-lowering effect of similar extent of glucose 
(600 mmol) and sodium bicarbonate (300 mmol) when 
administered orally to healthy neonatal calves. The 
combination of both substances in one treatment did 
not result in a noticeable additive effect on extracel-
lular K homeostasis.
Several mechanisms with the potential to cause a 
marked decline in plasma [K] must be considered. In 
addition to increased renal K excretion and altered 
transcellular distribution of K, an osmotically driven 
volume expansion of the extracellular space is also 
likely to reduce plasma [K]. Our current understanding 
of K homeostasis in mammals suggests that rapid cor-
rection of postprandial increases in plasma [K], having 
the potential to jeopardize the equilibrium of extracel-
lular [K], is achieved mainly through intracellular shifts 
of K (Youn and McDonough, 2009). In contrast, renal 
K regulation, although very efficient, has a lag time 
of hours and thus is unlikely to be responsible for the 
changes in plasma [K] observed within 60 to 120 min 
of treatment (Youn and McDonough, 2009). Similarly, 
the aldosterone-dependent K absorption from the large 
intestine lags several hours behind feed intake, because 
ingesta must reach the lower intestinal tract; thus, this 
was not considered in the present study (Rose and 
Post, 2001).
Figure 3. Mean plasma [glucose] ± SD relative to treatment in groups Gluc (300 mmol/L of glucose; ), NaBic (150 mmol/L NaHCO3; ?), 
and Combi (150 mmol/L NaHCO3 + 300 mmol/L glucose; □). Samples were obtained at the same time points in all groups but time points 
were spread apart slightly to improve clarity.
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Compartmental shifts of K have been reported not 
only after glucose administration, but also after admin-
istration of alkalinizing agents such as sodium bicarbon-
ate, and are associated with marked declines of extra-
cellular [K] (Burnell et al., 1956; Burnell and Scribner, 
1957; Smith and Etteldorf, 1961; Hundal et al., 1992). 
Alteration of the transcellular distribution of K trig-
gered by insulin and sodium bicarbonate is thought to 
occur through different pathways. Insulin-dependent 
cellular K uptake has been proposed to be mediated 
through activation of the Na-K-ATPase in response to 
an elevated plasma insulin concentration (Hundal et al., 
1992). In contrast, alkalinization with sodium bicarbon-
ate was proposed to cause a decrease in the extracellular 
H+ concentration, resulting in increased H+ transport 
out of the cell in exchange for Na through the Na/H 
exchanger, making extra Na available to be exchanged 
for K through the Na-K-ATPase pump.
Plasma volume expansion must be considered when-
ever osmotically active compounds readily absorbed 
from the gastrointestinal tract such as glucose or so-
dium bicarbonate are administered orally. The positive 
effect on plasma volume expansion of oral electrolyte 
solutions containing large amounts of glucose in calves 
has been reported previously (Brooks et al., 1996). 
In humans, plasma volume expansion was discussed 
as a probable factor contributing to the mild plasma 
potassium-lowering effect in some patients treated in-
travenously with sodium bicarbonate (Blumberg et al., 
1992). Comparison of the crude and volume-corrected 
changes of plasma [K] in the current study suggests 
that plasma volume expansion had the strongest effect 
on the decline of plasma [K] in NaBic and to some 
extent in Combi, but had no noticeable effect in Gluc 
(Figure 1).
Although the different test solutions used in the pres-
ent study could have altered intestinal K absorption, 
this effect was considered unlikely to affect the results 
presented here because none of the test solutions con-
tained K. Therefore, intestinal K absorption in the 
proximal intestinal tract was considered to be equally 
low in all groups.
Although baseline plasma [K] did not differ signifi-
cantly between groups, numerical differences between 
groups were larger than could be considered negligible 
(Figure 1). It remains unclear to what extent these dif-
ferences in baseline concentrations might have contrib-
uted to the observed treatment effects.
Figure 4. Mean plasma volume changes ± SD relative to treatment in groups Gluc (300 mmol/L of glucose; ), NaBic (150 mmol/L 
NaHCO3; ?), and Combi (150 mmol/L NaHCO3 + 300 mmol/L glucose; □). Samples were obtained at the same time points in all groups but 
time points were spread apart slightly to improve clarity.
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In the present study, proxies were used to assess the 
quantitative contribution of some of the above-men-
tioned mechanisms to the observed decline in plasma 
[K] during the first 120 min following oral treatment. 
Specifically, the changes in plasma glucose concentra-
tion determined during the first 120 min after treatment 
were used as a crude proxy for the concomitant increase 
of plasma insulin concentrations to assess the effect of 
Figure 5. Mean change in blood base excess (BE) relative to time zero (T0) ± SD (upper panel) and mean venous blood pH ± SD (lower 
panel) in groups Gluc (300 mmol/L of glucose; ), NaBic (150 mmol/L NaHCO3; ?), and Combi (150 mmol/L NaHCO3 + 300 mmol/L glucose; 
□). Samples were obtained at the same time points in all groups but time points were spread apart slightly to improve clarity.
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insulin-dependent cellular K uptake. This approach is 
supported by findings in monogastric species and calves 
indicating that the increase of plasma insulin concen-
tration after oral carbohydrate administration parallels 
the increase of plasma glucose (Stanley et al., 2002; 
Muto et al., 2005).
Although total renal K excretion did not differ 
between groups following oral treatment, the strong 
correlation of the maximum decrement in plasma [K] 
(Cmin-Kdiff) and AUCKDiff-240 with the total amount of K 
excreted in urine during 8 h following treatment sug-
gest the presence of a treatment effect in calves treated 
with oral glucose. This analysis does not allow us to 
determine the chronology of events, but the rapid onset 
of the intracellular translocation of K and the lag time 
of several hours of renal K regulation make it prob-
able that decreased renal K excretion is a consequence 
of decreased availability of extracellular K in animals 
treated with glucose. In contrast, in groups NaBic and 
Combi ,where the decline in plasma [K] was numerically 
smaller and plasma volume expansion was determined 
to be the main factor responsible for the decrease in 
plasma [K], the total amount of K available in the ex-
tracellular space and thus filtered in the renal glomeruli 
would be altered to a lesser degree.
The regression analysis conducted to assess the rela-
tive importance of each of the considered mechanisms 
for the observed plasma potassium-lowering effect in-
dicated that in calves treated with oral glucose alone, 
hypokalemia was triggered mainly by the insulin-de-
pendent intracellular shift of K, whereas plasma volume 
expansion did not appear to contribute to this effect 
in a significant manner. Oral administration of sodium 
bicarbonate, in contrast, triggered a decline in plasma 
[K] mainly through plasma volume expansion and to a 
lesser extent through compartmental K shifts related to 
the strong ion effect, as determined from the significant 
association of the decline in plasma [K] with plasma 
volume changes and blood BE. When combining both 
compounds in one treatment, the K-lowering effect was 
not potentiated and the regression analysis revealed 
that, in this group, mechanisms driving the decline of 
plasma [K] were almost identical to what was observed 
in animals treated with sodium bicarbonate alone, as 
suggested by the similar partial R2 of plasma volume 
change and BE in both groups. In particular, the double 
osmolarity of the test solution containing glucose and 
sodium bicarbonate did not enhance plasma volume 
expansion compared with the treatment with sodium 
bicarbonate alone. In contrast, the insulin-dependent 
intracellular K uptake appeared to have been mark-
edly blunted when glucose was combined with sodium 
bicarbonate compared with the treatment with glucose 
alone.
Although our results are in agreement with earlier 
studies reporting a strong hypokalemic effect of sodium 
bicarbonate (Burnell et al., 1956; Burnell and Scribner, 
1957; Smith and Etteldorf, 1961), recent studies have 
failed to reproduce any effect of sodium bicarbonate 
on extracellular K homeostasis in healthy individuals 
or in patients with end-stage renal failure (Blumberg 
et al., 1988; Allon and Shanklin, 1996; Kaplan et al., 
1997). The discrepancy between findings presented 
in this study and reports mentioned above could be 
related to differences in the dosage of sodium bicar-
bonate. Dosages used in the trials mentioned above 
ranged between 2 and 3 mmol/kg of BW administered 
intravenously as a hypertonic solution in between 5 and 
60 min (Blumberg et al., 1988; Kaplan et al., 1997). In 
contrast, the dosage of 300 mmol used in this study for 
a 40-kg calf is equivalent to approximately 7.5 mmol/
kg of BW, which, even when given orally with rapid 
intestinal absorption, could have a more pronounced 
osmotic and alkalinizing effect than the lower dose of 
sodium bicarbonate administered intravenously.
The role of alkalinization for the hypokalemic effect 
of sodium bicarbonate is controversial. Whereas some 
authors proposed that the hypokalemic effect depends 
on the concomitant presence of acidemia (Alfonzo et 
al., 2006; Parham et al., 2006), this is disputed by oth-
ers (Fraley and Adler, 1977). In humans and dogs, even 
mild acidemia was found to hamper insulin sensitivity 
of liver and peripheral tissues (Mackler et al., 1951; 
DeFronzo and Beckles, 1979; Van Putten et al., 1985; 
Arsenis and Livingston, 1986). Correcting acidemia is 
therefore believed to enhance insulin sensitivity and 
thereby the translocation of K into the cells. Accord-
ingly, in humans, the combination of parenteral glucose 
and insulin treatment with sodium bicarbonate was 
found to enhance the hypokalemic effect of insulin 
(Kim, 1996). The implication of this hypothesis, which 
is supported by studies (Koch and Kaske, 2008; Coskun 
et al., 2010) on K homeostasis in calves would be that 
the effect of both glucose and sodium bicarbonate, as 
well as the combination, could have a more pronounced 
K-lowering effect in diarrheic calves suffering from 
marked concomitant acidemia. Calves in the present 
study were healthy and did not have acidemia or meta-
bolic acidosis before or after treatment. Only mild and 
transient metabolic alkalosis was observed in animals in 
groups NaBic and Combi, and the combination of glu-
cose with sodium bicarbonate appeared to hamper the 
effect of glucose on extracellular K equilibrium rather 
than enhancing it.
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A possible explanation for this effect is the K-specific 
insulin resistance that presents an entity different and 
independent of the glucose-related insulin resistance, 
which has been described in states of K deprivation 
(Nørgaard et al., 1981). Even short-term K deprivation 
can result in a decrease in insulin-dependent cellular 
K uptake of up to 80%, whereas insulin-dependent 
glucose uptake remains unaffected (Choi et al., 2001). 
This mechanism has been understood as a protection 
against postprandial hypokalemia when diets rich in 
carbohydrates but low in potassium are ingested, as 
was the case in groups Gluc and Combi in the present 
study.
The main objective of the present study was to elu-
cidate the mechanism by which glucose and sodium 
bicarbonate after oral administration alter extracellu-
lar K homeostasis rather than directly comparing the 
hypokalemic effect of both compounds, as this would 
be of little value. Even though the same amount of 
both compounds on a molar basis was administered 
orally, it is difficult to estimate the amount of sodium 
bicarbonate absorbed from the gastrointestinal tract 
because varying amounts of bicarbonate may have been 
lost upon entering the acidic abomasum. Furthermore, 
it is unclear if, and to what extent, sodium bicarbonate 
might have been absorbed from the juvenile omasum 
in these calves, as this occurs in adult animals. Differ-
ences in the hypokalemic effect between groups could 
therefore be due to differences in bioavailability after 
oral treatment of both compounds.
In conclusion, we report a marked plasma potassium-
lowering effect of both sodium bicarbonate and glucose 
when administered orally to healthy neonatal calves. 
For sodium bicarbonate, the plasma potassium-lowering 
effect appeared to be largely driven by plasma volume 
expansion followed by intracellular translocation of K, 
whereas glucose caused a decline in plasma [K] mainly 
through an intracellular shift of K. The combination 
of both compounds did not have an additive effect on 
extracellular K homeostasis.
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